Study details
Enrolling now
Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot Trial
Wandercraft
NCT IDNCT07220733ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1/2
Target enrollment
5
Study length
about 4 months
Ages
18+
Locations
1 site in MA
About this study
This trial is testing the safety and feasibility of using a self-balancing exoskeleton to help patients recover after thoracic surgery. The exoskeleton helps patients stand and walk, even if they are weak or have balance problems. The goal is to see if this device can be used safely in an ICU setting.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use Self-balancing robotic exoskeleton (Atalante X)
PhasePhase 1/Phase 2
Primary goalIncidence of device- and procedure-related adverse events during exoskeleton use in ICU patients
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Primary: Incidence of device- and procedure-related adverse events during exoskeleton use in ICU patients